MYP_065751
Basic Information
NN2211 (Glucagon- Like Peptide 1 Derivative)
Metabolic Glucose metabolism Antidiabetic
Metabolic Glucose metabolism Antidiabetic Anti-diabetic
Standard
31 amino acids
C151H228N42O47
Standard
Sequence
HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG
Physicochemical Analysis
3383.68 Da
5.53
-1.15
-1.41
-0.0369
-0.25
0.57
0.06
15.64
69.35
0.1290
6990.00
6990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1444.28
-15.15
52.0
47.0
110.0
240.0
6.0
31.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0272352 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
GLP-1
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
γ-Glu-palmitoyl residue at position 21
Bio-Activity Profile
Anti-diabetic
Subcutaneously injected in Humans, in vivo; 39600 s
RECORD: Rec_0343028 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GLP-1
9606;32630
Structure & Mods
branched peptide architecture [Branched]
canonical L-amino-acid peptide [L]
Side-chain acyl/linker conjugation
Bio-Activity Profile
Antidiabetic GLP-1 receptor agonist Weight management
Human GLP-1 receptor
Clinical/Human: 13 h